NRC National Research Corporation - Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 4, 2026
$20.35
· of 52w range
· above low
· to high
$11.0152w low
$23.6852w high
Market Cap (MRQ)
$451M
P/E (TTM)
0.4
EPS (TTM)
$49.75
Revenue (TTM)
$140M
your badges
52W Range
$11–$24
Analyst Rating
BUY
Price Target
$26
P/E
0.4
ROE
42.0%
Net Profit Margin
4.2%
Your badge strip is empty — pin a metric anywhere on this page.
NRC Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$20.35
Market Cap (MRQ)
$451M
P/E (TTM)
0.4
EPS (TTM)
$49.75
Revenue (TTM)
$140M
ROE (TTM)
42.0%
Debt/Equity (MRQ)
14.4
52W Range
$11–$24
NRC Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
About National Research Corporation - Common Stock Company overview from Wikipedia
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska. The company changed its corporate name from National Research Corporation to NRC Health, Inc. in April 2026.
History
National Research Corporation was established in 1981 to provide performance measurement tools and insights for the healthcare industry.
In 1994, the Picker Institute was founded and began development of the Qualisys technology the following year. In 1998, National Research Corporation acquired Healthcare Research Systems, Inc., expanding its offerings in patient experience measurement.
In 2001, the company purchased the Picker Institute's healthcare survey business, enhancing its market presence in patient-centered research. Expansion continued in 2003 with the acquisition of Smaller World Communications, based in Canada.
The company entered the health risk assessment sector in 2005 through the acquisition of Geriatric Health Systems LLC. In 2006, it acquired TGI Group LLC, which led to the creation of The Governance Institute, a resource for healthcare governance education and research.
In 2009, National Research Corporation acquired My InnerView, a firm recognized for its long-term care quality and satisfaction surveys. This was followed in 2010 by the acquisition of OCS HomeCare, a provider of clinical and outcomes analytics for home health and hospice care.
In 2014, the company acquired Digital Assent, the first software platform to enable healthcare organizations to publish physician star ratings based on patient experience data.
In 2016, National Research Corporation rebranded as NRC Health, reflecting a broader commitment to human-centered care and consumer insights.
On February 11, 2020, NRC Health experienced a cyberattack that resulted in the temporary shutdown of its operations and raised concerns about the security of patient data maintained on behalf of its healthcare clients.
Awards
NRC Health is associated with several healthcare recognition programs, including the Consumer Choice Award, the AHCA/NCAL National Quality Award, and Excellence in Action. These programs acknowledge hospitals and long-term care providers based on performance metrics related to patient and resident satisfaction.
In 2010, the company was approved by the Centers for Medicare and Medicaid Services (CMS) as a vendor for the Home Health Consumer Assessment of Healthcare Providers and Systems (HHCAHPS) survey program.
In 2012 and 2013, Modern Healthcare identified NRC Health as the largest patient satisfaction measurement firm in the United States.
Products and services
Products and solutions provided by NRC Health follows the "Eight Dimensions of Patient-Centered Care" philosophy.
Under this strategy, the company provides:
Patient & Family Experience
Resident & Family Experience
Employee Engagement
Physician Engagement
The Consumer Assessment of Healthcare Providers and Systems (CAHPS) program
Market Insights
Healthcare Analytics
Clinical & Outcomes Analytics
Health Risk Assessments
Patient Outreach Programs
Integrated Solutions
The Institutes
CAHPS is a survey system, including HCAHPS, CGCAHPS, HHCAHPS, NHCAHPS, Pediatric HCAHPS, and ICHCAHPS.
Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗
sectorHealth Care
industryHealth Care
employees357
countryUS
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$137M2016-12-31 → 2025-12-31
EPS$50.002019-12-31 → 2025-12-31
Free Cash Flow·2016-12-31 → 2024-12-31
Net margin4.2%2016-12-31 → 2024-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | NRC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E (TTM) | 0.45Y avg ≈21.4 | ≈21.4 | · | · | |
| P/S (TTM) | 3.25Y avg ≈5.6 | ≈5.6 | 2.1 | Overvalued | |
| P/B (MRQ) | 68.85Y avg ≈14.4 | ≈14.4 | 3.1 | Overvalued | |
| Price / FCF (TTM) | 20.85Y avg ≈31.2 | ≈31.2 | · | · | |
| Price / Cash Flow (TTM) | 15.35Y avg ≈21.2 | ≈21.2 | 12.8 | Overvalued | |
| Price / Tangible Book (MRQ) | 101.3 | · | · | · | |
| PEG Ratio | ≈0.0 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | NRC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Operating Margin (TTM) | 10.5%5Y avg ≈29.1% | ≈29.1% | -0.07% | Weak | |
| Pretax Margin (TTM) | 6.7%5Y avg ≈27.7% | ≈27.7% | 0.46% | Weak | |
| Net Profit Margin (TTM) | 4.2%5Y avg ≈21.1% | ≈21.1% | -2.6% | Weak | |
| ROA (TTM) | 4.2%5Y avg ≈22.9% | ≈22.9% | 0.70% | Top tier | |
| ROE (TTM) | 42.0%5Y avg ≈55.8% | ≈55.8% | 10.9% | Top tier |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | NRC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Debt / Equity (MRQ) | 14.45Y avg ≈0.6 | ≈0.6 | 0.0 | High debt | |
| Current Ratio (MRQ) | 0.75Y avg ≈1.1 | ≈1.1 | 0.9 | Low liquidity | |
| Long-Term Debt / Equity (MRQ) | 13.1 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
| Metric | 5Y trend | NRC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue YoY | -4.0%5Y avg ≈0.76% | ≈0.76% | · | · | |
| Revenue CAGR 3Y | -3.2%5Y avg ≈-0.21% | ≈-0.21% | · | · | |
| Revenue CAGR 5Y | 0.61% | · | · | · | |
| EPS YoY | 4707.7%5Y avg ≈935.4% | ≈935.4% | · | · | |
| Net Income YoY | -53.2%5Y avg ≈-18.1% | ≈-18.1% | · | · | |
| EPS CAGR 3Y | 240.2%5Y avg ≈74.9% | ≈74.9% | · | · | |
| EPS CAGR 5Y | 103.0% | · | · | · | |
| Net Income CAGR 3Y | -28.5%5Y avg ≈-15.8% | ≈-15.8% | · | · | |
| Net Income CAGR 5Y | -20.8% | · | · | · |
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | NRC | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Revenue / Employee | ≈$384.8K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Dividends Yield, payout ratio, dividend history, 5Y CAGR
Annualized Payout≈$0.64
Growth Streak≈1
| Ex-date | Amount | Currency | Yield |
|---|---|---|---|
| Sep 25, 2026 | $0.16 | USD | ≈3.3% |
| Jun 26, 2026 | $0.16 | USD | ≈2.9% |
| Mar 27, 2026 | $0.16 | USD | ≈3.3% |
| Dec 26, 2025 | $0.16 | USD | ≈2.8% |
| Sep 26, 2025 | $0.12 | USD | ≈3.6% |
| Jun 27, 2025 | $0.12 | USD | ≈2.9% |
| Mar 28, 2025 | $0.12 | USD | ≈3.7% |
| Dec 27, 2024 | $0.12 | USD | ≈2.8% |
| Sep 27, 2024 | $0.12 | USD | ≈2.1% |
| Jun 28, 2024 | $0.12 | USD | ≈6.4% |
| Mar 27, 2024 | $0.12 | USD | ≈3.8% |
| Dec 28, 2023 | $0.12 | USD | ≈3.8% |
| Sep 28, 2023 | $0.12 | USD | ≈3.9% |
| Sep 15, 2023 | $1.00 | USD | ≈3.5% |
| Jun 29, 2023 | $0.12 | USD | ≈1.4% |
| Mar 30, 2023 | $0.12 | USD | ≈1.7% |
| Dec 29, 2022 | $0.12 | USD | ≈2.3% |
| Sep 29, 2022 | $0.24 | USD | ≈2.1% |
| Jun 29, 2022 | $0.24 | USD | ≈1.9% |
| Mar 30, 2022 | $0.24 | USD | ≈1.5% |
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
44.0%
Next Report
Oct 26, 2026
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2026 | Jul 27, 2026 | $0.31 | $0.14 | 119.2% |
| March 31, 2026 | $0.21 | — | — | |
| Dec. 31, 2025 | $0.16 | — | — | |
| Sept. 30, 2025 | $0.23 | — | — | |
| June 30, 2019 | $0.29 | $0.26 | 10.4% | |
| March 31, 2019 | $0.32 | $0.31 | 2.2% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| SG&A Expense | $55M | $45M | $47M | $43M | $39M | $34M | $33M | $31M | $30M | $28M | $27M | $25M | |
| Operating Expenses | $115M | $108M | $109M | $105M | $98M | $91M | $85M | $84M | $83M | $78M | $76M | $71M | |
| Operating Income | $23M | $35M | $40M | $47M | $50M | $43M | $43M | $35M | $34M | $31M | $26M | $28M | |
| Interest Expense | · | $3M | $862.0K | $1M | $2M | $2M | $2M | $2M | $82.0K | $190.0K | $220.0K | $305.0K | |
| Interest Income | $111.0K | $125.0K | $820.0K | $168.0K | $14.0K | $18.0K | $37.0K | $62.0K | $96.0K | $47.0K | $60.0K | $83.0K | |
| Other Non-op | $-95.0K | $-34.0K | $-41.0K | $-118.0K | $4.0K | $585.0K | $-462.0K | $885.0K | $50.0K | $302.0K | $1M | $18.0K | |
| Pretax Income | $18M | $33M | $40M | $43M | $49M | $41M | $41M | $35M | $34M | $31M | $27M | $28M | |
| Income Tax | $6M | $8M | $9M | $11M | $11M | $4M | $8M | $5M | $11M | $11M | $10M | $10M | |
| Net Income | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| EPS (Basic) | $50.00 | $1.05 | $1.26 | $1.28 | $1.47 | $1.48 | $1.30 | · | · | · | · | · | |
| EPS (Diluted) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | · | · | · | · | · | |
| Shares (Basic) | 22,383,000 | 23,703,000 | 24,540,000 | 24,922,000 | 25,422,000 | 25,170,000 | 24,809,000 | · | · | · | · | · | |
| Shares (Diluted) | 22,396,000 | 23,743,000 | 24,673,000 | 25,052,000 | 25,640,000 | 25,696,000 | 25,653,000 | · | · | · | · | · | |
| EBITDA | · | $35M | $40M | $47M | $50M | · | $43M | $35M | $34M | $31M | $26M | $32M |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $4M | $4M | $7M | $25M | $54M | $35M | $14M | $13M | $35M | $33M | $42M | $40M | |
| Receivables | $11M | $11M | $12M | $14M | $14M | $14M | $12M | $12M | $15M | $11M | $10M | $8M | |
| Prepaid Expense | $4M | $3M | $4M | $2M | $4M | $3M | $2M | $3M | $2M | $2M | $1M | $1M | |
| Other Current Assets | $520.0K | $692.0K | $940.0K | $1M | $982.0K | $2M | $2M | $224.0K | $35.0K | $35.0K | $34.0K | $994.0K | |
| Current Assets | $20M | $20M | $24M | $44M | $74M | $54M | $29M | $28M | $52M | $47M | $55M | $53M | |
| PP&E (Net) | · | $38M | $28M | $17M | $12M | $12M | $14M | $14M | $12M | $12M | $11M | $12M | |
| PP&E (Gross) | · | $74M | $64M | $51M | $46M | $43M | $42M | $45M | $40M | $38M | $35M | $35M | |
| Accum. Depreciation | · | $35M | $36M | $34M | $33M | $31M | $29M | $31M | $28M | $26M | $23M | $23M | |
| Goodwill | $66M | $66M | $62M | $62M | $62M | $57M | $58M | $58M | $58M | $58M | $58M | $58M | |
| Intangibles | $2M | $3M | $1M | $2M | $2M | $1M | $2M | $2M | $3M | $3M | $4M | $5M | |
| Other Non-current Assets | $3M | $4M | $3M | $3M | $3M | $3M | $3M | $2M | $2M | $768.0K | $293.0K | $234.0K | |
| Total Assets | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Accounts Payable | $1M | $1M | $1M | $1M | $2M | $1M | $1M | $613.0K | $593.0K | $765.0K | $614.0K | $830.0K | |
| Accrued Liabilities | $3M | $5M | $5M | $4M | $5M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Short-term Debt | $4M | $5M | $7M | $4M | $4M | $4M | $4M | $4M | $1M | $3M | $2M | $2M | |
| Current Liabilities | $37M | $36M | $36M | $33M | $40M | $32M | $38M | $47M | $32M | $32M | $44M | $28M | |
| Capital Leases | $744.0K | $1M | $2M | · | · | · | · | $676.0K | $87.0K | $110.0K | $103.0K | $167.0K | |
| Deferred Tax | $6M | $4M | $4M | $5M | $7M | $7M | $7M | $6M | $4M | $5M | $6M | $7M | |
| Other Non-current Liabilities | $3M | $4M | $4M | $2M | $3M | $4M | $2M | $1M | $935.0K | $777.0K | $575.0K | $541.0K | |
| Total Liabilities | $121M | $101M | $73M | $58M | $72M | $69M | $78M | $89M | $37M | $38M | $54M | $42M | |
| Long-term Debt | $79M | · | $37M | $22M | $27M | $31M | $34M | $38M | $1M | $4M | $6M | $8M | |
| Total Debt | · | $63M | $7M | $4M | $4M | · | $34M | $38M | $2M | $6M | $8M | $10M | |
| Common Stock | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | $30.0K | $30.0K | $26.0K | · | · | · | |
| Retained Earnings | $-17M | $-17M | $-31M | $-25M | $-36M | $-61M | $-93M | $-106M | $78M | $72M | $65M | $74M | |
| Treasury Stock | $153M | $132M | $99M | $78M | $50M | $44M | $34M | $29M | $37M | $33M | $32M | $30M | |
| AOCI | · | · | · | · | · | · | · | · | · | $-3M | $-3M | $-773.0K | |
| Stockholders' Equity | $14M | $31M | $49M | $72M | $85M | $64M | $33M | $19M | $90M | $83M | $74M | $88M | |
| Liabilities + Equity | $135M | $133M | $122M | $130M | $158M | $133M | $111M | $108M | $127M | $121M | $128M | $130M | |
| Shares Outstanding | 22,637,252 | 23,083,116 | 24,219,887 | 24,628,173 | 25,361,409 | 25,390,968 | 24,947,500 | 24,800,796 | 20,936,703 | · | · | · |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $8M | $6M | $6M | · | · | · | $6M | $5M | $5M | $4M | $4M | $4M | |
| Stock-based Comp | $3M | $284.0K | $935.0K | $1M | $623.0K | $680.0K | $1M | $2M | $2M | $2M | $1M | $742.0K | |
| Deferred Tax | $2M | $-664.0K | $-1M | $-2M | $-277.0K | $-134.0K | $1M | $1M | $-684.0K | $798.0K | $-1M | $107.0K | |
| Amort. of Intangibles | $389.0K | $264.0K | $140.0K | $180.0K | $320.0K | $318.0K | $374.0K | $662.0K | $610.0K | $654.0K | $995.0K | $876.0K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | $3M | |
| Operating Cash Flow | $26M | $35M | $38M | $36M | $46M | $41M | $41M | $40M | $28M | $27M | $22M | $26M | |
| CapEx | $11M | $15M | $16M | $10M | $6M | $4M | $5M | $6M | $5M | $4M | $3M | $2M | |
| Investing Cash Flow | $-11M | $-20M | $-16M | $-10M | $-9M | $-4M | $-5M | $-6M | $-6M | $-4M | $-1M | $-6M | |
| Stock Repurchased | $20M | $31M | $19M | $28M | $4M | · | · | · | · | · | $2M | · | |
| Net Stock Activity | · | $-31M | $-19M | $-28M | $-4M | · | · | · | · | · | $-2M | · | |
| Dividends Paid | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · | |
| Financing Cash Flow | $-16M | $-17M | $-41M | $-56M | $-18M | $-16M | $-36M | $-54M | $-21M | $-33M | $-17M | $-2M | |
| Net Change in Cash | $-94.0K | $-2M | $-18M | $-29M | $20M | $21M | $526.0K | $-22M | $2M | $-9M | $2M | $18M | |
| Taxes Paid | · | $8M | $9M | $12M | $11M | $5M | $7M | $3M | $13M | $10M | $9M | · | |
| Free Cash Flow | · | $19M | $22M | $26M | $41M | · | $36M | $34M | $24M | $23M | $19M | $24M | |
| Levered FCF | · | $17M | $22M | $26M | $40M | · | $35M | $33M | $23M | $23M | $19M | $24M |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 28.6% | |
| Net Margin | · | 17.3% | 20.8% | 21.0% | 25.3% | · | 25.3% | 25.1% | 19.5% | 18.8% | 17.2% | 18.4% | |
| Pretax Margin | · | 22.9% | 26.9% | 28.2% | 32.9% | · | 31.7% | 29.0% | 29.2% | 28.7% | 26.7% | 28.4% | |
| EBITDA Margin | · | 24.6% | 27.0% | 30.7% | 34.0% | · | 33.6% | 29.5% | 29.1% | 28.5% | 25.8% | 32.5% | |
| ROA | · | 19.4% | 24.5% | 22.1% | 25.8% | · | 29.6% | 25.5% | 18.5% | 16.5% | 13.6% | 15.1% | |
| ROE | · | 75.2% | 58.0% | 45.5% | 44.5% | · | 104.8% | 122.1% | 26.6% | 26.1% | 21.7% | 22.8% | |
| ROIC | · | 28.4% | 55.2% | 45.2% | 43.2% | · | 51.3% | 53.6% | 24.8% | 22.9% | 20.7% | 18.6% |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 0.5 | 0.7 | 1.3 | 1.8 | · | 0.8 | 0.6 | 1.6 | 1.5 | 1.3 | 1.9 | |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 | · | 0.7 | 0.5 | 1.5 | 1.4 | 1.2 | 1.7 | |
| Debt / Equity | · | 2.0 | 0.1 | 0.1 | 0.1 | · | 1.0 | 2.0 | 0.0 | 0.1 | 0.1 | 0.1 | |
| LT Debt / Equity | · | 1.9 | · | · | · | · | 0.9 | 1.8 | · | 0.0 | 0.0 | 0.1 | |
| Interest Coverage | · | 13.6 | 46.5 | 38.5 | 30.2 | · | 20.6 | 23.3 | 417.3 | 164.2 | 120.2 | 92.8 |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | 1.1 | 1.2 | 1.1 | 1.0 | · | 1.2 | 1.0 | 0.9 | 0.9 | 0.8 | 0.8 | |
| Receivables Turnover | · | 12.2 | 11.1 | 10.8 | 10.7 | · | 10.9 | 9.0 | 9.7 | 10.6 | 11.4 | 10.3 |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $1.36 | $2.02 | $2.92 | $3.36 | · | $1.32 | $0.77 | · | · | · | · | |
| Revenue / Share | · | $6.03 | $6.02 | $6.05 | $5.77 | · | · | · | · | · | · | · | |
| Cash Flow / Share | · | $1.46 | $1.54 | $1.45 | $1.81 | · | · | · | · | · | · | · | |
| Cash / Share | · | $0.18 | $0.27 | $1.02 | $2.14 | · | $0.54 | $0.52 | · | · | · | · | |
| Dividend / Share | $0.52 | $0.48 | $1.48 | $0.84 | $0.48 | $0.21 | $0.78 | · | · | · | · | · | |
| EPS (TTM) | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 | $1.45 | $1.26 | $2.28 | $2.28 | $2.28 | $2.28 | $2.28 |
Growth Rates
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.0% | -3.7% | -2.0% | 2.4% | 11.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -3.2% | -1.1% | 3.7% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.61% | · | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | 4707.7% | -16.8% | -1.6% | -13.0% | 0.69% | · | · | · | · | · | · | · | |
| EPS CAGR 3Y | 240.2% | -10.7% | -4.8% | · | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.0% | · | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -53.2% | -20.0% | -2.6% | -15.1% | 0.55% | · | · | · | · | · | · | · | |
| Net Income CAGR 3Y | -28.5% | -12.9% | -6.0% | · | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -20.8% | · | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 0.86% | · | · | · | · | · | · | · | · | · | · | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $137M | $143M | $149M | $152M | $148M | $133M | $128M | $120M | $118M | $109M | $102M | $99M | |
| Net Income TTM | $12M | $25M | $31M | $32M | $37M | $37M | $32M | $30M | $23M | $21M | $18M | $18M | |
| Market Cap | · | $407M | $958M | $919M | $1.05B | · | $1.65B | $946M | · | · | · | · | |
| Enterprise Value | · | $466M | $959M | $898M | $1.00B | · | $1.67B | $971M | · | · | · | · | |
| P/E | 0.4 | 17.0 | 31.6 | 29.4 | 28.4 | 29.5 | 52.3 | 16.7 | 16.4 | 8.3 | 7.0 | 6.1 | |
| P/S | · | 2.8 | 6.4 | 6.1 | 7.1 | · | 12.9 | 7.9 | · | · | · | · | |
| P/B | · | 13.0 | 19.6 | 12.8 | 12.3 | · | 50.0 | 49.6 | · | · | · | · | |
| P / Tangible Book | · | · | · | 104.3 | 48.0 | 192.1 | · | · | · | · | · | · | |
| P / Cash Flow | · | 11.8 | 25.1 | 25.3 | 22.7 | · | 40.2 | 23.7 | · | · | · | · | |
| P / FCF | · | 21.2 | 42.9 | 34.8 | 25.8 | · | 45.4 | 27.9 | · | · | · | · | |
| EV / EBITDA | · | 13.2 | 23.9 | 19.3 | 20.0 | · | 38.7 | 27.5 | · | · | · | · | |
| EV / FCF | · | 24.3 | 42.9 | 34.0 | 24.6 | · | 45.9 | 28.7 | · | · | · | · | |
| EV / Revenue | · | 3.3 | 6.5 | 5.9 | 6.8 | · | 13.0 | 8.1 | · | · | · | · | |
| Dividend Yield | · | 2.8% | 3.8% | 2.3% | 0.87% | · | 1.9% | 1.8% | · | · | · | · | |
| Earnings Yield | 266.4% | 5.9% | 3.2% | 3.4% | 3.5% | 3.4% | 1.9% | 6.0% | 6.1% | 12.0% | 14.2% | 16.3% | |
| Payout Ratio | · | 46.2% | 117.4% | 65.9% | 24.4% | · | 96.6% | 56.1% | 73.5% | 139.2% | 57.1% | · | |
| Annual Payout | $11M | $11M | $36M | $21M | $9M | $11M | $31M | $17M | $17M | $29M | $10M | · |
Income Statement
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $35M | $35M | $35M | $35M | $34M | $34M | $37M | $36M | $35M | $35M | $38M | $38M | $36M | $36M | $38M | $38M | |
| SG&A Expense | $23M | $13M | $14M | $12M | $18M | $10M | $11M | $11M | $11M | $11M | $11M | $12M | $12M | $12M | $11M | $11M | |
| Operating Expenses | $39M | $29M | $31M | $27M | $32M | $25M | $27M | $28M | $26M | $27M | $26M | $28M | $27M | $27M | $26M | $27M | |
| Operating Income | $-3M | $6M | $5M | $8M | $2M | $9M | $10M | $8M | $9M | $9M | $12M | $10M | $9M | $9M | $12M | $11M | |
| Interest Expense | · | · | · | $1M | $1M | $899.0K | · | $706.0K | $555.0K | $605.0K | · | $160.0K | $192.0K | $241.0K | $286.0K | $288.0K | |
| Interest Income | $20.0K | $35.0K | $30.0K | $41.0K | $21.0K | $19.0K | $22.0K | $34.0K | $25.0K | $44.0K | $41.0K | $256.0K | $273.0K | $250.0K | $134.0K | $15.0K | |
| Other Non-op | $2.0K | $30.0K | $-61.0K | $-45.0K | $4.0K | $7.0K | $-6.0K | $-12.0K | $-11.0K | $-5.0K | $-13.0K | $-12.0K | $-2.0K | $-14.0K | $-49.0K | $11.0K | |
| Pretax Income | $-5M | $4M | $3M | $6M | $581.0K | $8M | $9M | $7M | $8M | $8M | $11M | $10M | $9M | $9M | $9M | $11M | |
| Income Tax | $-1M | $1M | $1M | $2M | $687.0K | $2M | $2M | $2M | $2M | $2M | $3M | $2M | $2M | $2M | $3M | $3M | |
| Net Income | $-3M | $3M | $2M | $4M | $-106.0K | $6M | $7M | $6M | $6M | $6M | $9M | $8M | $7M | $7M | $7M | $8M | |
| EPS (Basic) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.28 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.30 | $0.28 | $0.27 | $0.34 | |
| EPS (Diluted) | $-0.15 | $0.14 | $49.58 | $0.18 | $-0.01 | $0.25 | $0.27 | $0.24 | $0.26 | $0.27 | $0.36 | $0.32 | $0.29 | $0.28 | $0.27 | $0.33 | |
| Shares (Basic) | 22,009,000 | 21,799,000 | · | 22,130,000 | 22,658,000 | 22,972,000 | · | 23,721,000 | 23,871,000 | 23,868,000 | · | 24,560,000 | 24,578,000 | 24,585,000 | · | 24,716,000 | |
| Shares (Diluted) | 22,009,000 | 21,911,000 | · | 22,130,000 | 22,658,000 | 22,974,000 | · | 23,745,000 | 23,915,000 | 23,963,000 | · | 24,695,000 | 24,716,000 | 24,738,000 | · | 24,847,000 | |
| EBITDA | $-3M | $6M | · | $8M | $2M | $9M | · | $8M | $9M | $9M | · | $10M | $9M | $9M | · | $11M |
Balance Sheet
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $3M | $3M | $4M | $2M | $5M | $3M | $4M | $3M | $485.0K | $2M | · | $4M | $22M | $24M | · | $28M | |
| Receivables | $9M | $11M | $11M | $13M | $12M | $11M | $11M | $11M | $10M | $11M | · | $14M | $12M | $14M | · | $15M | |
| Prepaid Expense | $5M | $6M | $4M | $4M | $5M | $6M | $3M | $5M | $5M | $6M | · | $6M | $6M | $6M | · | $4M | |
| Other Current Assets | $431.0K | $461.0K | $520.0K | $973.0K | $2M | $588.0K | $692.0K | $664.0K | $1M | $777.0K | · | $369.0K | $834.0K | $1M | · | $1M | |
| Current Assets | $23M | $20M | $20M | $20M | $25M | $20M | $20M | $21M | $17M | $20M | · | $25M | $41M | $45M | · | $49M | |
| PP&E (Net) | · | · | · | $41M | $42M | $40M | · | $36M | $34M | $32M | · | $26M | $23M | $19M | · | $16M | |
| PP&E (Gross) | · | · | · | $82M | $81M | $77M | · | $76M | $72M | $69M | · | $63M | $59M | $54M | · | $52M | |
| Accum. Depreciation | · | · | · | $41M | $38M | $37M | · | $40M | $39M | $37M | · | $37M | $36M | $35M | · | $36M | |
| Goodwill | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $66M | $62M | $62M | $62M | $62M | $62M | $62M | · | $62M | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $1M | $1M | · | $2M | $2M | $2M | · | $2M | |
| Other Non-current Assets | $3M | $3M | $3M | $2M | $2M | $3M | $4M | $6M | $2M | $3M | · | $4M | $5M | $4M | · | $3M | |
| Total Assets | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Accounts Payable | $1M | $2M | $1M | $1M | $1M | $2M | $1M | $3M | $1M | $2M | · | $1M | $2M | $1M | · | $1M | |
| Accrued Liabilities | $4M | $3M | $3M | $4M | $6M | $5M | $5M | $6M | $5M | $6M | · | $5M | $4M | $4M | · | $5M | |
| Short-term Debt | $4M | $4M | $4M | $4M | $4M | $3M | $5M | $4M | $8M | $8M | · | $5M | $5M | $5M | · | $4M | |
| Current Liabilities | $35M | $38M | $37M | $39M | $36M | $38M | $36M | $44M | $46M | $49M | · | $41M | $34M | $36M | · | $41M | |
| Capital Leases | · | · | $744.0K | · | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Deferred Tax | $6M | $6M | $6M | $3M | $4M | $5M | $4M | $4M | $4M | $4M | · | $5M | $5M | $5M | · | $5M | |
| Other Non-current Liabilities | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | · | $3M | $2M | $2M | · | $2M | |
| Total Liabilities | $130M | $121M | $121M | $121M | $120M | $106M | $101M | $97M | $79M | $84M | · | $62M | $56M | $60M | · | $67M | |
| Long-term Debt | $90M | · | · | · | · | · | · | $49M | $33M | $35M | · | $19M | $20M | $21M | · | $23M | |
| Total Debt | $94M | $78M | · | $80M | $81M | $62M | · | $49M | $33M | $35M | · | $5M | $5M | $5M | · | $4M | |
| Common Stock | $32.0K | $32.0K | $32.0K | $32.0K | $32.0K | $31.0K | $31.0K | $31.0K | $31.0K | $31.0K | · | $31.0K | $31.0K | $31.0K | · | $31.0K | |
| Retained Earnings | $-25M | $-18M | $-17M | $-15M | $-17M | $-14M | $-17M | $-21M | $-24M | $-27M | · | $-36M | $-17M | $-21M | · | $-29M | |
| Treasury Stock | $162M | $154M | $153M | $152M | $143M | $137M | $132M | $125M | $116M | $116M | · | $82M | $82M | $80M | · | $76M | |
| Stockholders' Equity | $7M | $13M | $14M | $14M | $21M | $30M | $31M | $35M | $40M | $37M | $49M | $58M | $78M | $75M | $72M | $68M | |
| Liabilities + Equity | $136M | $135M | $135M | $136M | $141M | $135M | $133M | $132M | $119M | $121M | · | $120M | $134M | $134M | · | $135M | |
| Shares Outstanding | 22,139,315 | 22,536,696 | 22,637,252 | 22,657,421 | 23,103,685 | 22,785,421 | 23,083,116 | 23,476,040 | 23,871,257 | 23,877,315 | · | 24,562,068 | 24,567,092 | 24,599,815 | · | 24,691,246 |
Cash Flow
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $2M | $2M | $1M | · | $1M | |
| Stock-based Comp | $7M | $2M | $2M | $925.0K | $307.0K | $171.0K | $188.0K | $189.0K | $-57.0K | $-36.0K | $258.0K | $68.0K | $305.0K | $304.0K | $290.0K | $291.0K | |
| Deferred Tax | $0 | $-36.0K | $3M | $-48.0K | $-2M | $2M | $-546.0K | $18.0K | $110.0K | $-246.0K | $-400.0K | $29.0K | $-373.0K | $-377.0K | $36.0K | $-486.0K | |
| Operating Cash Flow | $1M | $7M | $7M | $14M | $-1M | $7M | $6M | $9M | $7M | $12M | $12M | $10M | $9M | $8M | $8M | $10M | |
| CapEx | $1M | $2M | $1M | $4M | $3M | $3M | $4M | $2M | $5M | $4M | $4M | $4M | $4M | $3M | $2M | $4M | |
| Investing Cash Flow | $-1M | $-2M | $-1M | $-4M | $-3M | $-3M | $-4M | $-6M | $-5M | $-4M | $-4M | $-4M | $-4M | $-3M | $-2M | $-4M | |
| Stock Repurchased | $8M | $2M | $1.0K | $9M | $6M | $5M | $7M | $9M | $0 | $15M | $15M | $309.0K | $2M | $2M | $2M | $3M | |
| Net Stock Activity | · | $-2M | · | · | · | $-5M | · | · | · | $-15M | · | · | · | $-2M | · | · | |
| Dividends Paid | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $28M | $3M | $3M | $6M | $6M | |
| Financing Cash Flow | $718.0K | $-7M | $-4M | $-13M | $7M | $-5M | $-1M | $-17.0K | $-3M | $-13M | $-5M | $-24M | $-6M | $-6M | $-10M | $-10M | |
| Net Change in Cash | $780.0K | $-2M | $2M | $-3M | $3M | $-2M | $772.0K | $3M | $-1M | $-5M | $3M | $-19M | $-1M | $-1M | $-3M | $-5M | |
| Taxes Paid | · | · | · | $373.0K | $3M | $80.0K | $2M | $2M | $4M | $78.0K | $2M | $2M | $4M | $27.0K | $3M | $3M | |
| Free Cash Flow | · | $5M | · | · | · | $4M | · | · | · | $8M | · | · | · | $5M | · | · | |
| Levered FCF | · | · | · | · | · | $3M | · | · | · | $7M | · | · | · | $4M | · | · |
Profitability
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| Net Margin | -9.3% | 9.3% | · | 11.9% | -0.31% | 17.2% | · | 15.9% | 17.6% | 18.0% | · | 20.8% | 20.1% | 19.1% | · | 22.0% | |
| Pretax Margin | -12.8% | 12.6% | · | 18.1% | 1.7% | 23.0% | · | 20.4% | 23.8% | 23.2% | · | 26.5% | 26.1% | 24.7% | · | 28.8% | |
| EBITDA Margin | -9.2% | 16.0% | · | 22.4% | 4.7% | 25.6% | · | 22.3% | 25.3% | 24.8% | · | 26.2% | 25.9% | 24.7% | · | 29.5% | |
| ROA | -2.4% | 2.4% | · | 3.1% | -0.08% | 4.5% | · | 4.5% | 4.9% | 5.0% | · | 6.2% | 5.4% | 4.9% | · | 5.7% | |
| ROE | -23.5% | 14.9% | · | 16.9% | -0.34% | 17.4% | · | 12.3% | 10.5% | 11.4% | · | 12.5% | 9.9% | 8.9% | · | 11.0% | |
| ROIC | -2.3% | 4.5% | · | 5.4% | -0.28% | 7.0% | · | 7.5% | 9.0% | 9.4% | · | 12.5% | 8.8% | 8.8% | · | 11.8% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.7 | 0.5 | · | 0.5 | 0.7 | 0.5 | · | 0.5 | 0.4 | 0.4 | · | 0.6 | 1.2 | 1.3 | · | 1.2 | |
| Quick Ratio | 0.4 | 0.3 | · | 0.4 | 0.5 | 0.4 | · | 0.3 | 0.2 | 0.3 | · | 0.4 | 1.0 | 1.1 | · | 1.1 | |
| Debt / Equity | 14.4 | 5.8 | · | 5.6 | 3.8 | 2.1 | · | 1.4 | 0.8 | 0.9 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| LT Debt / Equity | 13.1 | 5.5 | · | 5.3 | 3.6 | 2.0 | · | 1.3 | 0.6 | 0.7 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | 5.3 | 1.5 | 9.6 | · | · | · | 14.5 | · | 62.2 | 48.8 | 37.4 | · | 38.6 |
Efficiency
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | 0.3 | 0.3 | · | 0.3 | |
| Receivables Turnover | 3.3 | 3.1 | · | 2.9 | 3.0 | 3.0 | · | 2.8 | 3.2 | 2.8 | · | 2.5 | 2.9 | 2.4 | · | 2.4 |
Per Share
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.30 | $0.60 | · | $0.63 | $0.92 | $1.30 | · | $1.47 | $1.68 | $1.55 | · | $2.36 | $3.16 | $3.04 | · | $2.74 | |
| Revenue / Share | $1.61 | $1.59 | · | $1.56 | $1.50 | $1.46 | · | $1.51 | $1.46 | $1.47 | · | $1.54 | $1.46 | $1.47 | · | $1.52 | |
| Cash Flow / Share | · | $0.33 | · | · | · | $0.29 | · | · | · | $0.50 | · | · | · | $0.31 | · | · | |
| Cash / Share | $0.15 | $0.11 | · | $0.10 | $0.23 | $0.11 | · | $0.15 | $0.02 | $0.07 | · | $0.16 | $0.92 | $0.96 | · | $1.15 | |
| Dividend / Share | $0.16 | $0.16 | $0.16 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | $1.12 | $0.12 | $0.12 | $0.12 | $0.24 | |
| EPS (TTM) | $49.75 | $49.89 | · | $0.69 | $0.75 | $1.02 | · | $1.13 | $1.21 | $1.24 | · | $1.16 | $1.17 | $1.21 | · | $1.37 |
Valuation (TTM)
| Metric | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $140M | $139M | · | $139M | $140M | $141M | · | $144M | $146M | $147M | · | $149M | $148M | $150M | · | $152M | |
| Net Income TTM | $6M | $9M | · | $16M | $18M | $24M | · | $27M | $29M | $30M | · | $29M | $29M | $30M | · | $35M | |
| Market Cap | $478M | $383M | · | $290M | $388M | $292M | · | $537M | $548M | $946M | · | $1.09B | $1.07B | $1.07B | · | $983M | |
| Enterprise Value | $568M | $458M | · | $367M | $464M | $351M | · | $582M | $581M | $979M | · | $1.09B | $1.05B | $1.05B | · | $959M | |
| P/E | 0.4 | 0.3 | · | 18.5 | 22.4 | 12.5 | · | 20.2 | 19.0 | 31.9 | · | 38.2 | 37.2 | 36.0 | · | 29.1 | |
| P/S | 3.4 | 2.8 | · | 2.1 | 2.8 | 2.1 | · | 3.7 | 3.7 | 6.4 | · | 7.3 | 7.2 | 7.2 | · | 6.5 | |
| P/B | 72.9 | 28.4 | · | 20.2 | 18.2 | 9.8 | · | 15.5 | 13.6 | 25.6 | · | 18.8 | 13.7 | 14.3 | · | 14.5 | |
| P / Tangible Book | · | · | · | · | · | · | · | · | · | · | · | · | 73.2 | 93.3 | · | 218.3 | |
| P / Cash Flow | · | 53.3 | · | · | · | 43.9 | · | · | · | 78.6 | · | · | · | 138.1 | · | · | |
| EV / Revenue | 4.1 | 3.3 | · | 2.6 | 3.3 | 2.5 | · | 4.0 | 4.0 | 6.6 | · | 7.3 | 7.1 | 7.0 | · | 6.3 | |
| Dividend Yield | 2.7% | 3.1% | · | 3.8% | 2.9% | 3.9% | · | 2.2% | 6.6% | 3.8% | · | 3.6% | 1.7% | 1.9% | · | 1.8% | |
| Earnings Yield | 230.6% | 293.8% | · | 5.4% | 4.5% | 8.0% | · | 4.9% | 5.3% | 3.1% | · | 2.6% | 2.7% | 2.8% | · | 3.4% | |
| Payout Ratio | · | 112.5% | · | · | · | 47.9% | · | · | · | 45.7% | · | · | · | 42.4% | · | · | |
| Annual Payout | $13M | $12M | · | $11M | $11M | $11M | · | $12M | $36M | $36M | · | $39M | $18M | $21M | · | $18M |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $137M | $143M | $149M | $152M | $148M |
| Operating Margin % | · | 24.6% | 27.0% | 30.7% | 34.0% |
| Net Income | $12M | $25M | $31M | $32M | $37M |
| Diluted EPS | $50.00 | $1.04 | $1.25 | $1.27 | $1.46 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Debt / Equity | · | 2.0 | 0.1 | 0.1 | 0.1 |
| Current Ratio | · | 0.5 | 0.7 | 1.3 | 1.8 |
| Quick Ratio | · | 0.4 | 0.5 | 1.2 | 1.7 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $19M | $22M | $26M | $41M |
Institutional owners (13F) 133 filers · $237.0M total · As of Sept. 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
133
Value held
$237.0M
New positions
18
Exited positions
11
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 18 (-1 vs prior Q) | 11 (+1 vs prior Q) | 43 (+14 vs prior Q) | 39 (-15 vs prior Q) | -77K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC | $43,797,714 | 2,030,492 | 18.48% | Shares |
| BlackRock, Inc. | $22,893,428 | 1,061,355 | 9.66% | Shares |
| MORGAN STANLEY | $18,534,465 | 859,269 | 7.82% | Shares |
| VANGUARD GROUP INC | $15,604,984 | 831,379 | 6.58% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $14,377,570 | 666,554 | 6.07% | Shares |
| DIMENSIONAL FUND ADVISORS LP | $10,595,956 | 491,228 | 4.47% | Shares |
| Willis Investment Counsel | $9,378,312 | 434,785 | 3.96% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $9,062,880 | 420,056 | 3.82% | Shares |
| FARMERS & MERCHANTS INVESTMENTS INC | $7,132,099 | 330,649 | 3.01% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $7,018,533 | 325,384 | 2.96% | Shares |
| STATE STREET CORP | $6,483,381 | 298,384 | 2.74% | Shares |
| HEARTLAND ADVISORS INC | $6,471,000 | 300,000 | 2.73% | Shares |
| Bank of New York Mellon Corp | $5,440,710 | 252,235 | 2.30% | Shares |
| NORTHERN TRUST CORP | $5,138,900 | 238,243 | 2.17% | Shares |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | $4,053,434 | 187,920 | 1.71% | Shares |
| WELLS FARGO & COMPANY/MN | $3,874,460 | 179,623 | 1.63% | Shares |
| AQR CAPITAL MANAGEMENT LLC | $2,635,976 | 122,206 | 1.11% | Shares |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $2,444,140 | 113,312 | 1.03% | Shares |
| Northwest & Ethical Investments L.P. | $2,208,121 | 102,370 | 0.93% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $2,096,604 | 97,200 | 0.88% | Shares |
| GOLDMAN SACHS GROUP INC | $2,087,458 | 96,776 | 0.88% | Shares |
| JANE STREET GROUP, LLC | $1,884,679 | 87,375 | 0.80% | Shares |
| FIFTH THIRD BANCORP | $1,841,475 | 85,372 | 0.78% | Shares |
| BANK OF AMERICA CORP /DE/ | $1,789,145 | 82,946 | 0.75% | Shares |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1,762,808 | 81,725 | 0.74% | Shares |
| COMERICA BANK | $1,687,723 | 89,916 | 0.71% | Shares |
| Linden Thomas Advisory Services, LLC | $1,679,311 | 77,854 | 0.71% | Shares |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $1,675,644 | 77,684 | 0.71% | Shares |
| Quantinno Capital Management LP | $1,577,892 | 73,152 | 0.67% | Shares |
| CITADEL ADVISORS LLC | $1,382,529 | 64,095 | 0.58% | Shares |
| TWO SIGMA INVESTMENTS, LP | $1,357,573 | 62,938 | 0.57% | Shares |
| ENVESTNET ASSET MANAGEMENT INC | $1,354,184 | 62,781 | 0.57% | Shares |
| SEI INVESTMENTS CO | $1,027,834 | 47,651 | 0.43% | Shares |
| ALPS ADVISORS INC | $1,015,365 | 47,073 | 0.43% | Shares |
| Williams Jones Wealth Management, LLC. | $901,626 | 41,800 | 0.38% | Shares |
| AMERICAN CENTURY COMPANIES INC | $831,847 | 38,565 | 0.35% | Shares |
| Squarepoint Ops LLC | $798,112 | 37,001 | 0.34% | Shares |
| US BANCORP \DE\ | $715,175 | 33,156 | 0.30% | Shares |
| Nuveen, LLC | $653,959 | 30,318 | 0.28% | Shares |
| HSBC HOLDINGS PLC | $634,793 | 29,539 | 0.27% | Shares |
| Daiwa Securities Group Inc. | $629,218 | 29,171 | 0.27% | Shares |
| Creative Planning | $624,487 | 28,952 | 0.26% | Shares |
| MARSHALL WACE, LLP | $502,193 | 23,282 | 0.21% | Shares |
| Empirical Finance, LLC | $431,400 | 20,000 | 0.18% | Shares |
| Invesco Ltd. | $429,847 | 19,928 | 0.18% | Shares |
| Cove Street Capital, LLC | $417,063 | 32,634 | 0.18% | Shares |
| OSAIC HOLDINGS, INC. | $389,338 | 18,050 | 0.16% | Shares |
| AMERIPRISE FINANCIAL INC | $366,928 | 17,007 | 0.15% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $351,591 | 16,300 | 0.15% | Put option |
| ALLIANCEBERNSTEIN L.P. | $321,007 | 18,905 | 0.14% | Shares |
Activists & 5%+ owners 6 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Common Property Trust, Common Property Trust LLC, Amandla, LLC, Beans Patrick E., Hays Michael D. ×3 filings | June 12, 2026 | 45.70% | Amendment | · | SEC |
| Thomas Richardson, as the Trustee of Common Property Trust and as Manager of Common Property Trust LLC, Common Property Trust, Common Property Trust LLC ( ×2 filings | March 5, 2024 | · | Initial filing | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the Amandla MK Trust, Amandla MK Trust ×9 filings | Jan. 4, 2024 | · | Initial filing | · | SEC |
| Patrick E. Beans, as the Special Holdings Direction Adviser under the K/I/E Trust Under Agreement 10/24/18, K/I/E Trust Under Agreement 10/24/18 | March 15, 2021 | · | Initial filing | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009), K/I/E/ Trust Under Agreement 3/9/09 (f/k/a Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009) | April 25, 2018 | · | Initial filing | · | SEC |
| Kent E. Endacott, as the Special Holdings Direction Adviser under the Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009, Michael and Karen Hays Grandchildren’s Trust dated March 9, 2009 | June 14, 2013 | · | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 27 insiders · 13 officers · 11 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Trent S Green | Chief Executive Officer | June 1, 2025 A | 500,000 | 0 | 0 | $0 |
| Shane R Harrison | EVP & Chief Financial Officer | Feb. 17, 2026 P | 8,000 | 1 | 0 | $98,160 |
| Kevin R Karas | SVP Finance, CFO, Treas & Secy | Feb. 28, 2023 S | 5,384 | 0 | 0 | $0 |
| Steven D. Jackson | President | Oct. 1, 2020 F | 55,567 | 0 | 0 | $0 |
| Susan L Henricks | President and COO | Jan. 7, 2014 A | 7,823 | 0 | 0 | $0 |
| Joseph W Carmichael | President | May 9, 2008 F | 41,872 | 0 | 0 | $0 |
| Helen Hrdy | EVP & Chief Operating Officer | Dec. 15, 2025 M | 140,518 | 0 | 0 | $0 |
| Jona S Raasch | COO, NRC Health | April 3, 2023 S | 1,688 | 0 | 0 | $0 |
| Jason Russell Rau | Executive Vice President | March 12, 2026 A | 60,000 | 0 | 0 | $0 |
| David Burik | EVP, Strategic Insights | Jan. 5, 2026 A | 100,000 | 0 | 0 | $0 |
| Hays Michael D. | Chairman | Jan. 5, 2026 M | 20,154 | 0 | 0 | $0 |
| Jordan Nicole Freeman | Chief Accounting Officer | July 31, 2025 P | 771 | 0 | 0 | $0 |
| Andrew Monnich | Chief Corp. Development Off. | April 7, 2025 A | 100,000 | 0 | 0 | $0 |
| Parul Bhandari | Director | June 23, 2026 A | 7,697 | 0 | 0 | $0 |
| Penny Ann Wheeler | Director | June 23, 2026 A | 7,697 | 0 | 0 | $0 |
| Stephen H Lockhart | Director | June 23, 2026 A | 7,697 | 0 | 0 | $0 |
| Donald M Berwick | Director | June 23, 2026 A | 7,697 | 0 | 0 | $0 |
| John N Nunnelly | Director | June 23, 2026 A | 40,363 | 0 | 0 | $0 |
| Joann M Martin | Director | June 29, 2021 A | 138,955 | 0 | 0 | $0 |
| Barbara Mowry | Director | May 15, 2020 M | 42,902 | 0 | 0 | $0 |
| Gail L Warden | Director | May 9, 2017 A | 10,263 | 0 | 0 | $0 |
| Paul C Schorr III | Director | Oct. 28, 2013 G | 34,802 | 0 | 0 | $0 |
| Beans Patrick E. | 10% owner | May 12, 2025 P | 35,003 | 0 | 0 | $0 |
| Common Property Trust | 10% owner | Dec. 31, 2024 G | 4,755,317 | 0 | 0 | $0 |
| Amandla MK Trust | 10% owner | Dec. 31, 2024 G | 0 | 0 | 0 | $0 |
| Michael & Karen Hays Grandchildren's Trust Dated March 9, 2009 | 10% owner | March 11, 2021 S | 0 | 0 | 0 | $0 |
| Karen S Hays | 10% owner | Feb. 12, 2010 G | 0 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 21 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| ROSC · Lattice Strategies Trust | 0.38% | 12,032 NS | July 31, 2026 | N-PORT |
| IWC · iShares Trust | 0.06% | 40,256 SH | Sept. 11, 2026 | Daily |
| IWO · iShares Trust | 0.02% | 111,072 SH | Sept. 11, 2026 | Daily |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0.01% | 13,039 SH | Oct. 2, 2026 | Daily |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0.01% | 68,097 SH | Aug. 19, 2026 | Daily |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0.01% | 12,633 SH | Aug. 19, 2026 | Daily |
| IWM · iShares Trust | 0.01% | 301,953 SH | Sept. 11, 2026 | Daily |
| DFAS · Dimensional ETF Trust | 0.01% | 62,228 NS | July 31, 2026 | N-PORT |
| RSSL · Global X Funds | 0.01% | 5,634 NS | July 31, 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0.00% | 560 NS | July 31, 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0.00% | 2,149 NS | July 31, 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0.00% | 1,985 NS | July 31, 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0.00% | 17,485 NS | July 31, 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0.00% | 4,118 NS | July 31, 2026 | N-PORT |
| ITOT · iShares Trust | 0.00% | 23,452 SH | Sept. 11, 2026 | Daily |
| IWV · iShares Trust | 0.00% | 3,867 SH | Sept. 3, 2026 | Daily |
| DFUS · Dimensional ETF Trust | 0.00% | 2,478 NS | July 31, 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0.00% | 151,126 SH | Aug. 19, 2026 | Daily |
| VTI · VANGUARD INDEX FUNDS | 0.00% | 498,279 SH | Aug. 19, 2026 | Daily |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0.00% | 995 SH | Aug. 19, 2026 | Daily |
| SMLF · iShares Trust | · | 66,767 SH | Sept. 11, 2026 | Daily |
NRC Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 5 analysts
BUY
Median target
$26.00
+27.8%
1 20.0%
Strong Buy
3 60.0%
Buy
1 20.0%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
1 analysts · 2026-09-27Mean target $26.00 +27.8%
Low$26.00
Mean$26.00
High$26.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
Latest News Recent headlines mentioning this company
US Nuclear Regulator Seeks Simpler Environmental Reviews To Boost Nuclear Expansion
ZeroHedge · 2 months, 3 weeks ago
The Best Nuclear Energy Stocks to Buy and Hold for Decades
Nasdaq · 4 months ago
In 10 Years, Will You Wish You'd Bought NuScale Power Stock Right Now?
Nasdaq · 4 months, 3 weeks ago
Oklo vs. NuScale Power: Both Are Falling in 2026, but Only One Is Worth Buying Now
Nasdaq · 5 months ago
New Jersey Governor Sherrill Lifts 40-Year Nuclear Moratorium
ZeroHedge · 5 months, 3 weeks ago
This $10 Nuclear Energy Stock Could Be Your Ticket to Millionaire Status
Nasdaq · 5 months, 3 weeks ago
NuScale Power Is Down 80% -- That's Great News for Long-Term Investors
Nasdaq · 6 months ago
"A Defining Moment": Nano Nuclear Submits Construction Permit For Kronos Reactor In Illinois
ZeroHedge · 6 months ago
Oklo Just Scored an NRC License. Should You Buy OKLO Stock Here?
Yahoo Finance · 6 months, 2 weeks ago
"Demand For Critical Isotopes Rising, Supply Limited": Oklo Lands First NRC License & Another DOE Milestone
ZeroHedge · 6 months, 2 weeks ago
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 4, 2026